240 related articles for article (PubMed ID: 9287968)
1. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids.
Debelenko LV; Emmert-Buck MR; Zhuang Z; Epshteyn E; Moskaluk CA; Jensen RT; Liotta LA; Lubensky IA
Gastroenterology; 1997 Sep; 113(3):773-81. PubMed ID: 9287968
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
[TBL] [Abstract][Full Text] [Related]
4. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
5. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids.
Azzoni C; Doglioni C; Viale G; Delle Fave G; De Boni M; Caruana P; Ferraro G; Bordi C
Am J Surg Pathol; 1996 Apr; 20(4):433-41. PubMed ID: 8604810
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of 11q allelic losses in digestive endocrine tumors.
D'adda T; Pizzi S; Azzoni C; Bottarelli L; Crafa P; Pasquali C; Davoli C; Corleto VD; Delle Fave G; Bordi C
Hum Pathol; 2002 Mar; 33(3):322-9. PubMed ID: 11979373
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1.
Dong Q; Debelenko LV; Chandrasekharappa SC; Emmert-Buck MR; Zhuang Z; Guru SC; Manickam P; Skarulis M; Lubensky IA; Liotta LA; Collins FS; Marx SJ; Spiegel AM
J Clin Endocrinol Metab; 1997 May; 82(5):1416-20. PubMed ID: 9141526
[TBL] [Abstract][Full Text] [Related]
8. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung.
Debelenko LV; Brambilla E; Agarwal SK; Swalwell JI; Kester MB; Lubensky IA; Zhuang Z; Guru SC; Manickam P; Olufemi SE; Chandrasekharappa SC; Crabtree JS; Kim YS; Heppner C; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Collins FS; Travis WD; Emmert-Buck MR
Hum Mol Genet; 1997 Dec; 6(13):2285-90. PubMed ID: 9361035
[TBL] [Abstract][Full Text] [Related]
9. Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach.
Eissele R; Anlauf M; Schäfer MK; Eiden LE; Arnold R; Weihe E
Digestion; 1999; 60(5):428-39. PubMed ID: 10473967
[TBL] [Abstract][Full Text] [Related]
10. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
Bordi C; Falchetti A; Azzoni C; D'Adda T; Canavese G; Guariglia A; Santini D; Tomassetti P; Brandi ML
Am J Surg Pathol; 1997 Sep; 21(9):1075-82. PubMed ID: 9298884
[TBL] [Abstract][Full Text] [Related]
11. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
Bordi C; Corleto VD; Azzoni C; Pizzi S; Ferraro G; Gibril F; Delle Fave G; Jensen RT
J Clin Endocrinol Metab; 2001 May; 86(5):2236-42. PubMed ID: 11344233
[TBL] [Abstract][Full Text] [Related]
12. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.
Solcia E; Capella C; Fiocca R; Rindi G; Rosai J
Am J Surg Pathol; 1990 Jun; 14(6):503-13. PubMed ID: 1970928
[TBL] [Abstract][Full Text] [Related]
13. Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?
Cadiot G; Laurent-Puig P; Thuille B; Lehy T; Mignon M; Olschwang S
Gastroenterology; 1993 Aug; 105(2):579-82. PubMed ID: 8101501
[TBL] [Abstract][Full Text] [Related]
14. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
Solcia E; Rindi G; Silini E; Villani L
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
[TBL] [Abstract][Full Text] [Related]
15. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.
Rindi G; Bordi C; Rappel S; La Rosa S; Stolte M; Solcia E
World J Surg; 1996 Feb; 20(2):168-72. PubMed ID: 8661813
[TBL] [Abstract][Full Text] [Related]
16. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
[TBL] [Abstract][Full Text] [Related]
17. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy DM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963924
[TBL] [Abstract][Full Text] [Related]
19. [Gastric carcinoid--pathogenesis and treatment].
Bründler R; Gebbers JO; Criblez D
Schweiz Med Wochenschr; 1999 Jun; 129(25):945-50. PubMed ID: 10422189
[TBL] [Abstract][Full Text] [Related]
20. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
